Neurological Diseases: MS and Alzheimer's

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to Lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is a characteristic feature of Multiple Sclerosis (MS)?

  • Demyelination of central nervous system white matter (correct)
  • Complete restoration of nerve impulse propagation
  • Increased production of myelin
  • Inflammation of peripheral nervous system

At what age range is Multiple Sclerosis most commonly diagnosed?

  • 20 to 45 years (correct)
  • 45 to 65 years
  • 0 to 20 years
  • 65 years and older

Which of the following is NOT a frequently affected area of the central nervous system in MS?

  • Cerebellum
  • Brainstem
  • Cerebral cortex (correct)
  • Optic chiasm

Which method is NOT typically used for the diagnosis of Multiple Sclerosis?

<p>Blood pressure monitoring (A)</p> Signup and view all the answers

What is the primary mechanism suspected in the pathogenesis of Multiple Sclerosis?

<p>Autoimmune mechanisms (D)</p> Signup and view all the answers

What is a common initial manifestation of Multiple Sclerosis?

<p>Trigeminal neuralgia (C)</p> Signup and view all the answers

Which of the following is NOT a recommended treatment for managing symptoms of Multiple Sclerosis?

<p>Cholinesterase inhibitors (B)</p> Signup and view all the answers

What percentage of new dementia cases are accounted for by Alzheimer’s disease in Western countries?

<p>65% (A)</p> Signup and view all the answers

Which of the following findings is considered a major pathological hallmark of Alzheimer’s disease?

<p>Neurofibrillary tangles (A)</p> Signup and view all the answers

What cognitive assessment tool is commonly used to assess global cognitive abilities in Alzheimer’s patients?

<p>Mini-Mental State Examination (B)</p> Signup and view all the answers

Which of the following conditions is NOT a characteristic issue faced by patients with Alzheimer’s disease?

<p>Severe sensory loss (A)</p> Signup and view all the answers

What is a common side effect of cholinesterase inhibitors used for treating Alzheimer’s disease?

<p>Weight loss (A)</p> Signup and view all the answers

What is the estimated global prevalence of dementia projected to be by the year 2050?

<p>48 million (A)</p> Signup and view all the answers

What condition may patients with Alzheimer's disease be at a higher risk of developing?

<p>Temporomandibular joint abnormalities (D)</p> Signup and view all the answers

What is the main goal of therapy for Alzheimer's disease?

<p>To slow disease progression (A)</p> Signup and view all the answers

Flashcards

Multiple Sclerosis (MS)

A neurological disease characterized by inflammation, demyelination, and scarring in the central nervous system's white matter.

Age of Onset of MS

Typically between 20 and 45 years old.

MS Gender Predominance

More common in women than men by a ratio of 2:1.

MS Symptoms

Symptoms depend on affected CNS areas, including visual changes, limb weakness, spasticity, ataxia, and bladder/bowel dysfunction.

Signup and view all the flashcards

MS Diagnosis

No single test, but relies on finding evidence of the disease's spread (dissemination in space), often involving MRI, CSF analysis, and evoked potentials.

Signup and view all the flashcards

Alzheimer's Disease (AD)

A progressive type of dementia, characterized by memory loss and difficulties with daily tasks, thinking, and speaking.

Signup and view all the flashcards

Dementia

A group of brain disorders that cause a decline in cognitive ability and impair daily functioning.

Signup and view all the flashcards

Trigeminal Neuralgia (TGN)

A severe facial pain condition, often described as electric shock-like.

Signup and view all the flashcards

Cholinesterase Inhibitors

Medications used to treat mild-to-moderate Alzheimer's by increasing levels of acetylcholine in the brain.

Signup and view all the flashcards

Mini-Mental State Examination

A simple cognitive test used to assess overall cognitive function (mental abilities).

Signup and view all the flashcards

Oral Health Considerations (MS Patients)

Dental care for patients must avoid elective procedures during MS disease flares due to mobility and airway risks.

Signup and view all the flashcards

Oral Health Considerations (AD Patients)

AD patients have a higher risk of dental problems (e.g., cavities, gum disease) compared to healthy people.

Signup and view all the flashcards

Amyloid Plaques

Abnormal protein deposits found in the brains of people with Alzheimer's.

Signup and view all the flashcards

Neurofibrillary Tangles

Abnormal protein fibers that build up inside brain cells in Alzheimer's disease.

Signup and view all the flashcards

Study Notes

Neurological Diseases

  • Neurological diseases are a broad category, including conditions like Multiple Sclerosis and Alzheimer's Disease.
  • This presentation focuses on the epidemiology, clinical manifestations, diagnosis, treatment, and oral health considerations for these conditions.

Multiple Sclerosis

  • Epidemiology & Etiology:
    • MS is characterized by inflammation, demyelination, and scarring (gliosis) in the central nervous system (CNS).
    • Myelin is crucial for nerve impulse transmission; its destruction slows or blocks these impulses.
    • The onset typically occurs between 20 and 45 years of age.
    • MS is more common in women than men (2:1 ratio).
    • The cause remains unknown but is associated with genetic susceptibility.
    • Autoimmune mechanisms are likely involved in its pathogenesis.
  • Clinical Features:
    • Symptoms vary depending on the affected areas of the CNS.
    • Common manifestations include visual changes, limb weakness, spasticity, ataxia, bladder and bowel dysfunction, and sensory impairment.
  • Diagnosis:
    • There's no single definitive test for MS.
    • Diagnosis relies on evaluating evidence of dissemination in space.
    • Common diagnostic tools include MRI, cerebrospinal fluid (CSF) analysis, and evoked potentials.
  • Management:
    • Therapy for MS is categorized into three types: acute attack treatment, disease-modifying therapies, and symptomatic therapy.
    • Treatment strategies include steroids, interferons, monoclonal antibodies, and symptomatic medication like anticonvulsants, benzodiazepines, and pain medications.
  • Oral Health Considerations:
    • Individuals with MS might experience trigeminal neuralgia (electric shock-like pain) as a presenting symptom.
    • Facial weakness and paralysis are also possible.
    • Elective dental treatment should be avoided during acute exacerbations due to potential mobility and airway compromise.

Alzheimer's Disease

  • Epidemiology & Etiology :
    • Alzheimer's Disease (AD) is the prevalent form of dementia.
    • It's a progressive disease that leads to memory loss and other cognitive impairments.
    • It begins with mild memory problems and progresses to difficulty with daily tasks and communication impairments.
    • AD involves parts of the brain controlling thought, memory, and language.
    • Globally, dementia prevalence is estimated at 24 million and projected to rapidly increase by 2050.
    • AD constitutes up to 65% of new dementia cases in Western countries.
    • In Saudi Arabia, AD affects approximately 130,000 individuals.
    • AD is characterized by amyloid plaques and neurofibrillary tangles in the brain which are absent in healthy individuals.
    • Massive apoptosis (programmed cell death) occurs in later stages in the brain tissue.
  • Clinical Features:
    • The disease typically progresses through stages, beginning with mild memory loss and cognitive impairment.
    • Common symptoms include difficulty with familiar tasks, misplacing items, poor decision-making, and changes in mood or personality.
  • Diagnosis:
    • Diagnosis often involves a Mini-Mental State Examination (MMSE) to assess cognitive abilities, along with neurological testing and potentially PET scans, MRI, and CSF analysis.
  • Management:
    • Currently, no cure exists for AD.
    • Treatment focuses on slowing the disease progression, using strategies like cholinesterase inhibitors (approved by the FDA for mild to moderate cases) and newer monoclonal antibodies.
    • Side effects like nausea, vomiting, diarrhea, weight loss, bradycardia, and syncope are possible, when using medications approved by the US Food and Drug Administration to treat the condition
  • Oral Health Considerations:
    • Patients with AD might be at higher risk for oral health problems like caries, periodontal disease, and temporomandibular joint issues.
    • Dental care during acute exacerbations should be limited and focus on preventative measures and patient safety.
    • Caregiver involvement can be beneficial, since they can verify information or assist in providing information that better aids the patient's understanding.

References & Further Reading

  • Step-up to medicine 5th edition
  • Harrison's Principles of Internal Medicine 20th edition
  • NEJM
  • Amboss

Studying That Suits You

Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

Quiz Team

Related Documents

Use Quizgecko on...
Browser
Browser